We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor intervention.
- Authors
Peirce, Susan; Findley, Harry; Prince, Chengyu; Dasgupta, Anindya; Cooper, Todd; Durden, Donald
- Abstract
Purpose: Studies of SF1126, an RGDS targeted, water-soluble prodrug of LY294002, are currently nearing completion in two adult Phase I trials. Herein, we performed a preclinical evaluation of SF1126 as a PI-3K inhibitor for Phase I trials in the treatment of recurrent neuroblastoma (NB). Methods: The effects of SF1126 on pAkt-MDM2 cell signaling, proliferation, apoptosis, and migration were determined using a panel of NB cell lines, and anti-tumor activity was determined using a xenograft model of NB. Results: SF1126 blocks MDM2 activation, IGF-1 induced activation of Akt, and the upregulation of survivin induced by IGF-1. It also increases sensitivity to doxorubicin in vitro and was found to exhibit marked synergistic activity in combination with doxorubicin. Treatment disrupts the integrin αvβ3/αvβ5-mediated organization of the actin cytoskeleton as well as the α4β1/α5β1-mediated processes essential to metastasis. In vivo, SF1126 markedly inhibits tumor growth in NB xenografted mice ( P < 0.05). Conclusions: A pan PI-3 kinase inhibitor has potent antitumor activity and induces apoptosis in multiple neuroblastoma cell lines. The observed effects of SF1126 on the p-Akt-MDM2-survivin axis suggest a patient selection paradigm in which NB tumors with increased pAkt-MDM2-survivin signaling may predict response to SF1126 alone or in combination with standard chemotherapy regimens that contain anthracyclines.
- Subjects
NEUROBLASTOMA; PROTEIN kinases; CELLULAR signal transduction; ENZYME inhibitors; CANCER relapse; TUMOR growth; APOPTOSIS; CELL proliferation
- Publication
Cancer Chemotherapy & Pharmacology, 2011, Vol 68, Issue 2, p325
- ISSN
0344-5704
- Publication type
Article
- DOI
10.1007/s00280-010-1486-7